Correlation of Early Metastatic Response by<sup>123</sup>I-Metaiodobenzylguanidine Scintigraphy With Overall Response and Event-Free Survival in Stage IV Neuroblastoma

2003164 citationsJournal Article

Authors

Katherine K. Matthay · Institut Gustave Roussy

Véronique Edeline · Institut Gustave Roussy

J. Lumbroso · Institut Gustave Roussy

Marie Laure Tanguy · Institut Gustave Roussy

Bernard Asselain · Institut Gustave Roussy

Jean Michel Zucker · Institut Gustave Roussy

Dominique Valteau‐Couanet

Abstract

Semiquantitative MIBG score early in therapy provides valuable prognostic information for overall response and EFS, which may be useful in tailoring treatment.

Topics & Keywords

Neuroblastoma Research and Treatments Cancer therapeutics and mechanisms Cancer, Hypoxia, and Metabolism

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 21, Issue 13, pp. 2486-2491

DOI: 10.1200/jco.2003.09.122

Field-Weighted Citation Impact: 3.93